Skip to main content
. 2021 Oct 22;6(20):e151477. doi: 10.1172/jci.insight.151477

Figure 3. Comparison of SARS-CoV-2 antibody profiles of RecoVax, NaiveVax, HospNoVax, and OutPtNoVax cohorts 4–6 weeks after vaccination or infection.

Figure 3

TAb antibody response (A), SNAb levels (B), and avidity (C) 4–6 weeks after vaccination or infection in RecoVax (red circle; n = 16), NaiveVax (blue triangle; n = 44), HospNoVax (green square; n = 43), and OutPtNoVax (violet diamond; n = 35) individuals. Horizontal black lines represent median values and whiskers represent 95% CI. Wilcoxon rank-sum was used for paired comparison while Kruskal-Wallis test was used for the comparison of 3 or more groups.